Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-021282

Options or other derivatives

  • Chief Scientific Officer acquired 115,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Barone Francesca Chief Scientific Officer 2025-02-12 Grant or award · Stock Option (Right to Buy) +115,000 115,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…